| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132c66008d28ff8f35da64f837953588 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-626 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-283 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2015-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64ea7c80f9bb116564a2c4d50e0b25d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b890ad5c1cb20135518fac3dc494b0a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44298ba3a7173359a506c78a211ccc0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5135bbf633cc8beb1d88e8059b43aa60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_986d6ffb33cafd38e0063cf5e220544a |
| publicationDate |
2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3091031-A1 |
| titleOfInvention |
Combination of a bispecific antibody with an immune modulating molecule for the treatment of a tumor |
| abstract |
Described is a combination of (i) a multifunctional antibody having specificity for an antigen present on a tumor cell and having specificity for an antigen present on a natural killer (NK) cell and (ii) at least one agent modulating an immune checkpoint molecule for the treatment of a tumor. The antibody may be a bispecific CD30/CD16 antibody and the agent can be anti-CTLA-4, anti-PD1 and ant-CD 137. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110461357-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023006082-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019179421-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019198051-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2774711-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112119097-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112119097-B |
| priorityDate |
2015-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |